Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

3

Revenue 2017

MabThera/Rituxan

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. MabThera/Rituxan was produced by Roche.

A new decade of disruption: meeting the biosimilar challgenge

A new decade of disruption: meeting the biosimilar challgenge As the dust settles on the first ten years of disruption, the spotlight is now on the future as more leading MAbs, including Humira (adalimumab), MabThera (rituximab), Avastin (bevacizumab) and Lucentis

Mylan deal with Roche clears path to biosimilar Herceptin launch

Mylan deal with Roche clears path to biosimilar Herceptin launch Aside from Herceptin, and biosimilars of Roche's Avastin (bevacizumab) and Rituxan/MabThera (rituximab) are also starting to reach the market.

Mundipharma to launch first MabThera biosimilar in EU

Mundipharma to launch first MabThera biosimilar in EU The European Medicines Agency has approved MabThera (rituximab) biosimilar Truxima for use in all of the cancer blockbuster's licensed indications, becoming the first copycat of its kind to win regulatory ... Mundipharma. It showed comparable preclinical,

2016: The year when deal-makers took stock?

2016: The year when deal-makers took stock? Canada for biosimilar versions of Rituxan (rituximab) and Herceptin (trastuzumab). .

Celgene bid to push Revlimid beyond myeloma blocked again

Celgene bid to push Revlimid beyond myeloma blocked again The RELEVANCE study looked at combining Revlimid (lenalidomide) with Roche’s Rituxan (rituximab) as a first-line treatment for patients with follicular lymphoma, one of the most common types of ... grade non-Hodgkin’s lymphoma (NHL), comparing the

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years....
Success breeds success
This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....
Turning learning into action: The challenge of behaviour change
...

Infographics